Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0670
-0.0050 (-6.94%)
Apr 28, 2026, 4:10 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 44.15 million as of April 28, 2026. Its market cap has decreased by -49.45% in one year.
Market Cap
44.15M
Enterprise Value
35.42M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 44.15M, a decrease of -54.02%. That is a compound annual growth rate of -17.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 44.15M | -4.61% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 830.65M |
| Healius | 384.85M |
| Australian Clinical Labs | 363.08M |
| Monash IVF Group | 284.43M |
| Rhythm Biosciences | 61.93M |
| Cryosite | 51.25M |
| INOVIQ | 46.46M |
| Genetic Signatures | 32.94M |